Doximity, Inc. $DOCS Shares Sold by Comerica Bank

Key Points

• Comerica Bank has reduced its stake in Doximity, Inc. by 8.1%, selling 7,500 shares, leaving them with 84,762 shares valued at approximately $4.92 million.
• Director Timothy S. Cabral sold 10,000 shares of Doximity stock for a total of $600,000, representing a 61.12% decrease in their ownership.
• Doximity's recent earnings report indicated an earnings per share of $0.36, beating expectations and demonstrating a year-over-year revenue growth of 15.2%.

Comerica Bank decreased its position in Doximity, Inc. (NASDAQ:DOCS - Free Report) by 8.1% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 84,762 shares of the company's stock after selling 7,500 shares during the period. Comerica Bank's holdings in Doximity were worth $4,919,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Amalgamated Bank increased its holdings in Doximity by 0.3% in the first quarter. Amalgamated Bank now owns 60,928 shares of the company's stock valued at $3,536,000 after buying an additional 186 shares in the last quarter. Greenleaf Trust increased its stake in shares of Doximity by 5.4% during the first quarter. Greenleaf Trust now owns 4,492 shares of the company's stock worth $261,000 after purchasing an additional 230 shares in the last quarter. Spire Wealth Management increased its stake in shares of Doximity by 73.2% during the first quarter. Spire Wealth Management now owns 615 shares of the company's stock worth $36,000 after purchasing an additional 260 shares in the last quarter. Allworth Financial LP increased its stake in shares of Doximity by 104.0% during the first quarter. Allworth Financial LP now owns 563 shares of the company's stock worth $32,000 after purchasing an additional 287 shares in the last quarter. Finally, Brooklyn Investment Group increased its stake in shares of Doximity by 70.7% during the first quarter. Brooklyn Investment Group now owns 746 shares of the company's stock worth $43,000 after purchasing an additional 309 shares in the last quarter. Hedge funds and other institutional investors own 87.19% of the company's stock.

Doximity Price Performance

DOCS traded up $1.25 on Thursday, reaching $68.55. 693,138 shares of the company's stock were exchanged, compared to its average volume of 2,264,390. The stock has a market cap of $12.84 billion, a PE ratio of 68.55, a P/E/G ratio of 4.10 and a beta of 1.37. Doximity, Inc. has a twelve month low of $35.32 and a twelve month high of $85.21. The stock's fifty day moving average price is $62.50 and its 200-day moving average price is $60.11.

Doximity (NASDAQ:DOCS - Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The company reported $0.36 earnings per share for the quarter, topping analysts' consensus estimates of $0.31 by $0.05. Doximity had a net margin of 36.60% and a return on equity of 21.75%. The firm's revenue for the quarter was up 15.2% on a year-over-year basis. During the same quarter last year, the firm earned $0.28 EPS. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. As a group, research analysts predict that Doximity, Inc. will post 0.99 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of analysts have recently commented on the stock. Piper Sandler boosted their target price on shares of Doximity from $65.00 to $69.00 and gave the stock an "overweight" rating in a research note on Monday, August 11th. Bank of America boosted their target price on shares of Doximity from $55.00 to $62.00 and gave the stock a "neutral" rating in a research note on Wednesday, June 25th. Wells Fargo & Company boosted their target price on shares of Doximity from $55.00 to $62.00 and gave the stock an "equal weight" rating in a research note on Monday, August 4th. Zacks Research cut shares of Doximity from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, August 20th. Finally, The Goldman Sachs Group set a $50.00 target price on shares of Doximity and gave the stock a "neutral" rating in a research note on Wednesday, May 21st. Two analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and eleven have given a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $66.21.

Insider Buying and Selling

In other Doximity news, Director Kira Scherer Wampler sold 2,000 shares of the business's stock in a transaction dated Friday, August 1st. The shares were sold at an average price of $57.09, for a total value of $114,180.00. Following the transaction, the director directly owned 16,618 shares in the company, valued at $948,721.62. The trade was a 10.74% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Timothy S. Cabral sold 10,000 shares of the business's stock in a transaction dated Wednesday, June 25th. The shares were sold at an average price of $60.00, for a total transaction of $600,000.00. Following the completion of the transaction, the director owned 6,360 shares in the company, valued at $381,600. The trade was a 61.12% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 32,000 shares of company stock worth $1,929,380. 31.30% of the stock is owned by insiders.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.